NT-proBNP-guided therapy was dominant ( i.e. , more effective and less costly ) over symptom-guided therapy , saving $ @,@ USD ( @ to @ % confidence interval -LSB- CI -RSB- : $ @,@ to $ @,@ ) per patient , with incremental effectiveness of +@ life-years and +@ QALYs .